Advisor Group Holdings, Inc. Red Hill Biopharma Ltd. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.14 - $695.9 $420 - $2.09 Million	-3,000 Reduced 39.47%	4,600 $0
Q3 2022 Nov 14, 2022	BUY	$0.5 - $523.8 $1,500 - $1.57 Million	3,000 Added 65.22%	7,600 $4,000
Q1 2022 May 04, 2022	SELL	$1.65 - $3.12 $32,176 - $60,843	-19,501 Reduced 80.91%	4,600 $1.37 Million
Q3 2021 Nov 05, 2021	BUY	$4.55 - $10.36 $81,449 - $185,454	17,901 Added 288.73%	24,101 $110,000
Q2 2021 Aug 02, 2021	SELL	$5.98 - $7.51 $8,970 - $11,265	-1,500 Reduced 19.48%	6,200 $43,000
Q1 2021 May 13, 2021	BUY	$6.98 - $11.29 $39,786 - $64,352	5,700 Added 285.0%	7,700 $57,000
Q4 2020 Feb 10, 2021	SELL	$7.81 - $10.39 $13,277 - $17,663	-1,700 Reduced 45.95%	2,000 $16,000
Q3 2020 Nov 12, 2020	BUY	$6.34 - $10.83 $9,510 - $16,245	1,500 Added 68.18%	3,700 $37,000
Q1 2020 May 18, 2020	BUY	$3.51 - $6.17 $7,721 - $13,574	2,200 New	2,200 $10,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.